PL BioScience Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 28

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 15

PL BioScience General Information

Description

Operator of a biotech platform designed to provide animal-component-free supplements for cell growth. The company offers human-derived and fully lab-made platelet lysate products, produced under rigorous standards to meet the growing demand for cell culture media for all phases of research and development with stem cells, enabling researchers and manufacturers in regenerative medicine, cell therapy, and biopharmaceutical development to access safer, ethically sourced, and scalable cell culture supplements.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Auf der Hüls 184-186
  • 52068 Aachen
  • Germany
+49 0241
Primary Industry
Biotechnology
Other Industries
Other Consumer Non-Durables
Vertical(s)
Corporate Office
  • Auf der Hüls 184-186
  • 52068 Aachen
  • Germany
+49 0241

PL BioScience Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PL BioScience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) Completed Generating Revenue
6. Accelerator/Incubator 25-Feb-2025 Completed Generating Revenue
5. Later Stage VC (Series A) 08-Aug-2024 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
3. Later Stage VC (Series A) 21-May-2021 Completed Generating Revenue
2. Grant 01-Jan-2020 Completed Generating Revenue
1. University Spin-Out 01-Jan-2015 Completed Generating Revenue
To view PL BioScience’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PL BioScience Patents

PL BioScience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026234149-A1 Artificial platelet lysate, methods for preparation and uses thereof Pending 07-May-2025
EP-4276173-A1 Stable human platelet lysate composition, methods and uses thereof Inactive 10-May-2022
EP-4522196-A1 Stable human platelet lysate composition, methods and uses thereof Pending 10-May-2022
US-20250320456-A1 Stable human platelet lysate composition, methods and uses thereof Pending 10-May-2022
WO-2023218351-A1 Stable human platelet lysate composition, methods and uses thereof Inactive 10-May-2022 C12N5/0644
To view PL BioScience’s complete patent history, request access »

PL BioScience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PL BioScience Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Scale Up.NRW Accelerator/Incubator
Avant Bio Growth/Expansion Minority
better ventures (Germany) Angel Group Minority
D11Z.Ventures Venture Capital Minority
Goodface Capital Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

PL BioScience FAQs

  • When was PL BioScience founded?

    PL BioScience was founded in 2015.

  • Where is PL BioScience headquartered?

    PL BioScience is headquartered in Aachen, Germany.

  • What is the size of PL BioScience?

    PL BioScience has 28 total employees.

  • What industry is PL BioScience in?

    PL BioScience’s primary industry is Biotechnology.

  • Is PL BioScience a private or public company?

    PL BioScience is a Private company.

  • What is PL BioScience’s current revenue?

    The current revenue for PL BioScience is .

  • How much funding has PL BioScience raised over time?

    PL BioScience has raised $13M.

  • Who are PL BioScience’s investors?

    Scale Up.NRW, Avant Bio, better ventures (Germany), D11Z.Ventures, and Goodface Capital are 5 of 15 investors who have invested in PL BioScience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process